BS ISO 24651:2022
$167.15
Biotechnology. Biobanking. Requirements for human mesenchymal stromal cells derived from bone marrow
Published By | Publication Date | Number of Pages |
BSI | 2022 | 36 |
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | National foreword |
7 | Foreword |
8 | Introduction |
9 | 1 Scope 2 Normative references 3 Terms and definitions |
13 | 4 Abbreviated terms and symbols |
15 | 5 General requirements 5.1 General 5.2 Personnel, facilities and equipment |
16 | 5.3 Reagents, consumables and other supplies 5.4 Management of information and data 6 Collection of bone marrow samples and associated data 6.1 Information about the bone marrow donor |
17 | 6.2 Anatomical collection site 6.3 Collection volume 6.4 Collection procedure 6.4.1 General |
18 | 6.4.2 Obtaining bone marrow by puncturing into the intramedullary canal 6.4.3 Obtaining bone marrow by aspirate 7 Transport of bone marrow samples or hBM-MSCs and associated data to the biobank 8 Reception and traceability of bone marrow or hBM-MSCs and associated data |
19 | 9 Isolation and expansion of hBM-MSCs 9.1 Processes 9.2 Unique identification 9.3 Testing for infectious agents 9.4 Isolation of hBM-MSCs from bone marrow samples obtained by puncturing into the intramedullary canal and primary culture |
20 | 9.5 Isolation of hBM-MSCs from bone marrow samples obtained by aspirate and primary culture 9.6 Subculture and limited expansion 10 Characterization of hBM-MSCs 10.1 General |
21 | 10.2 Viability 10.3 Morphology 10.4 Population doubling time and subculture/passage 10.4.1 PDT |
22 | 10.4.2 Subculture/passage 10.5 Cell population purity 10.6 In vitro self-renewal assessment 10.7 Proliferation |
23 | 10.8 Differentiation capability — In vitro multilineage differentiation 10.8.1 General 10.8.2 In vitro adipogenic differentiation 10.8.3 In vitro chondrogeneic differentiation |
24 | 10.8.4 In vitro osteogenic differentiation 10.9 Immunophenotyping by flow cytometry |
25 | 10.10 Paracrine secretion/expression (protein-based assay of secretome) 10.11 Immunoregulation (modulation of immune cells) |
26 | 10.12 Microbial contamination 11 Quality control |
27 | 12 Storage |
28 | 13 Thawing 14 Disposal 15 Distribution of hBM-MSCs — Information for users |
29 | 16 Transport of hBM-MSCs 16.1 General |
30 | 16.2 hBM-MSCs frozen in ampoules or cryovials 16.3 Living hBM-MSC cultures |
31 | Annex A (informative) Preparation of human bone marrow mononuclear cells (hBM-MNCs) |
32 | Bibliography |